Search Results

You searched for : dolutegravir  

	ViiV Healthcare and Medicines Patent Pool extends voluntary licensing agreement to enable access to long-acting injectable HIV treatment It builds on the voluntary license for CAB LA for HIV pre-exposure prophylaxis (PrEP), enabling increased access to innovative long-acting injectables for HIV ... Jul 15
	We can do better so that all people with HIV live healthy normal lifespans People living with HIV must take care of one’s mental health and wellbeing.... Jun 11
	Are we on track to end AIDS, end viral hepatitis and end STIs by 2030? My message is to connect, reconnect, and recommit to ending AIDS by 2030 - and - do it by bringing along other disease areas as well... Jun 14
	ViiV Healthcare receives EU Marketing Authorisation for Tivicay, a treatment for children living with HIV in Europe Tivicay contains dolutegravir, an integrase strand transfer inhibitor for use in combination with other antiretroviral agents for the treatment of HIV... Jan 15
	ViiV Healthcare receives EU Marketing Authorisation for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay ... Jan 13
	Top Indian Pharma stocks for short term gain : January 2021 Aarti Drugs, Laurus Labs, Granules India, Abbot India, Divis Lab and JB Chem - Medicircle top picks for short term gain... Jan 13
	Top Ten Mid Cap Indian Pharma Stocks ; January 2021 Top ten mid cap Indian pharma stocks , January 2021... Jan 07
	ViiV Healthcare announces CHMP positive opinion for the first-ever dispersible-tablet formulation of dolutegravir, Tivicay, a treatment for children living with HIV in Europe Dolutegravir is the first integrase inhibitor available as a dispersible tablet for children... Nov 13
	Trial results reveal that long-acting injectable cabotegravir as PrEP is highly effective in preventing HIV acquisition in women The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), ... Nov 10
	GSK's Dovato holds against Tenofavir Alafenamide Fumarate for HIV1 patients GSK two drug combination is as good as 3 drug regimen which is presently continued for HIV 1 patients... Oct 09
	ViiV Healthcare announces dolutegravir plus lamivudine for treatment-naïve adults with HIV-1 Findings showed that the 2-drug regimen (2DR) of dolutegravir plus lamivudine continued to offer non-inferior efficacy... Oct 05
	ViiV Healthcare to present long-term safety and efficacy data for 2-drug regimen Data presented may shift the treatment paradigm to 2-drug regimens (2DRs) for people living with HIV ... Oct 01
	GSK delivers Q2 sales of £7.6 billion GSK reports their firs quarter 2020 results... Jul 30
	WHO: access to HIV medicines severely impacted by COVID-19 Countries seek innovative ways to mitigate the impact of disruptions and keep HIV medicine services going ... Jul 13
14 Matching result(s) found!

Trending Now
	The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
	Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
	58 Students from SRM Medical College Selected for Union Government Research Programmes and Grants September 16, 2026
	Handpickd Questions the Role of Science in Food with ‘Science-Less’ Newspaper CampaignSeptember 16, 2026
	As Women’s Cancer Burden Rises, Integrated Care Emerges as The Next Frontier in Cancer TreatmentSeptember 16, 2026
	Odia Superstar Babushaan Mohanty Inaugurates Manoj Das Library at Utkal Gaurav International SchoolSeptember 16, 2026
	Yashoda Hospitals, Somajiguda Successfully Treats 10-Month-Old with Complex Heart Condition Through Staged ApproachSeptember 16, 2026
	Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
	Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
	Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
	ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
	From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
	WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
	BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
	Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
	Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
	Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
	Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026
	Dr. Reddy's Laboratories Launches Nationwide Educational Initiative to Strengthen India's Obesity Care WorkforceSeptember 14, 2026
	IIM Bodh Gaya Hosts Convergence 3.0: The Next Frontier of Healthcare SectorSeptember 14, 2026